Accession to Tuberculosis Treatment: Individual and Social Vulnerability Elements
Introduction: Tuberculosis (TB) remains as a major public health problem, being the second infectious disease to cause death all over the world. The Directly Observed Treatment (DOT) is one of the recommended strategies to control this disease. The accession in this mode of treatment is integrated into the Tuberculosis Control Program (PCT), this program also provide socio-economic incentives as the distribution of food baskets, bus passes and breakfast. Moreover, public policies for social protection help both family development and social vulnerability. Tuberculosis is still associated with social exclusion and marginalization of the population subjected to poor living conditions and limited access to public services.
Objective: Analyze the potential accession to tuberculosis treatment related to individual and social vulnerability aspects.
Methods: Cross-sectional, qualitative study, conducted with 39 individuals diagnosed with tuberculosis and in treatment for at least 30 days in the city of Campina Grande, Paraiba, Brazil. 20 markers were used as analysis units, with the possibility of score responses from one to three. The lower scores indicate lower potential of adherence to treatment, while the highest ones express greater potential accession.
Results: markers that were more related to score one and indicated lower potential adherence to tuberculosis treatment were: tuberculosis impact on labor; conception of health-disease causality and work process (employment status). In contrast, markers that were more closely related to the score three that resonate with greater adherence capability to tuberculosis treatment were: Drug use, life (housing situation) and treatment difficulties in the disease course.
Conclusion: The instrument used allowed the presentation of low potential markers for adherence to tuberculosis treatment. Therefore, it is recommended the use of markers in Primary Health Care for monitoring adherence to tuberculosis treatment.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).